Please login to the form below

Not currently logged in
Email:
Password:

ICS

This page shows the latest ICS news and features for those working in and with pharma, biotech and healthcare.

Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients

Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients

During the trial, patients were randomised to receive either PT027 or albuterol rescue, in addition to their usually prescribed maintenance ICS, with or without additional controller medicines.

Latest news

More from news
Approximately 1 fully matching, plus 35 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 18 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....